Navigation Links
Infant Vaccines Produce Autism Symptoms in New Primate Study by University of Pittsburgh Scientists
Date:5/19/2008

Routine Safety Study That Government Scientists Refused To Do Illustrates Vaccine Program And Mercury Health Risks Says SafeMinds

ATLANTA, May 19 /PRNewswire-USNewswire/ -- Findings released Friday showed that infant monkeys given vaccines officially recommended by the CDC and the American Academy of Pediatrics (AAP) exhibited autism-like symptoms. Lead investigator Laura Hewitson of the University of Pittsburgh and colleagues presented study results at the International Meeting for Autism Research (IMFAR) in London. Safety studies of medicines are typically conducted in monkeys prior to use in humans, yet such basic research on the current childhood vaccination regimen has never before been done.

The abstracts presented at IMFAR, the world's top autism science conference, describe biological changes and altered behavior in vaccinated macaques that are similar to those observed in children with autism. Unvaccinated animals showed no such adverse outcomes. The vaccines given were those recommended for U.S. infants in the 1990s, including several with the mercury preservative thimerosal and the Measles-Mumps-Rubella vaccine. Rates of autism spectrum disorder among children born in the 1990s surged dramatically, from about 1 in 5,000 to 1 in 150 children.

"This research underscores the critical need for more investigation into immunizations, mercury, and the alterations seen in autistic children," stated Lyn Redwood, director of SafeMinds. "SafeMinds calls for large scale, unbiased studies that look at medical conditions associated with autism and the effects of vaccines given as a regimen."

The group's request for research echoes that of Dr. Bernadine Healy, Former NIH Director, in a CBS interview earlier this week. She asserted that public health officials have been too quick to dismiss an autism-vaccine connection when the research has been insufficient. The government recently conceded a federal vaccine court case which agreed that a child regressed into autism as a result of 9 vaccines given on one day.

"The full implications of this primate study await publication of the research in a scientific journal," noted Theresa Wrangham, president of SafeMinds. "But we can say that it demonstrates how the CDC evaded their responsibility to investigate vaccine safety questions. Vaccine safety oversight should be removed from the CDC and given to an independent agency."

More information about SafeMinds (including neurodevelopmental disorders, autism and mercury exposure) may be found at http://www.safeminds.org

CONTACT: Lyn Redwood

404/932-1786

Theresa Wrangham

404/934-0777


'/>"/>
SOURCE SafeMinds
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Shows Physician Judgment is Important in Reducing Rate of RSV-Related Hospitalizations Among High-Risk Infants
2. The COSHAR Foundation Launches National Childhood Immunization Awareness Campaign During National Infant Immunization Week (April 19-26)
3. Pregnant Women Need Omega-3 to Boost Infant Development
4. Leukemia Therapy With Imatinib During Pregnancy May Cause Infant Abnormalities
5. Infant Formula Manufacturers Again under Ethical Cloud: Marketing Gimmick Linked to Serious Illnesses
6. MedImmune Presents New Pharmaco-Economic Data at American Academy of Pediatrics Regarding Infants at High Risk for RSV
7. New Data Show That GlaxoSmithKlines Rotarix(R) Could Be Given With Other Routine Infant Vaccines in the U.S.
8. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
9. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
10. New Patent Awarded for Antigen-Sparing Vaccines that Elicit Robust Immunity
11. 92 Medicines and Vaccines now in Development for HIV/AIDS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... , December 2, 2016 bioLytical Laboratories, ein Weltführer ... bei den Mitgliedern des Apothekenbundes von Kenia eingeführt. ... ... INSTI HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ...      (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) ...
(Date:12/2/2016)... , Dec. 2, 2016 Boston Scientific Corporation ... agreement to acquire certain manufacturing assets and capabilities of ... NVC) advanced biological tissue business, as well as a ... $75 million in cash. The Neovasc advanced biological tissue ... the Boston Scientific Lotus™ Valve System. * Upon ...
(Date:12/2/2016)... 2016 Lianluo Smart Limited (Nasdaq: ... which develops, markets and sells medical devices and ... and international markets, recently attended the ... New Progress Forum, co-hosted by the Institute of ... , Guangdong Provincial People,s Hospital and Cardiology Department ...
Breaking Medicine Technology:
(Date:12/4/2016)... ... ... James Earl Jones is known for myriad roles on stage and screen, he has ... the forthcoming episodes examines mammogram techniques; a very important part of preventative medicine. , ... detection. Like any other disease, treatments have a much higher chance of success if ...
(Date:12/4/2016)... CA (PRWEB) , ... December 04, 2016 , ... ... without undergoing major cosmetic surgery can now take advantage of a cosmetic procedure ... advanced skin rejuvenation treatment that reduces the appearance of age spots, fine ...
(Date:12/2/2016)... ... ... Lori G. Cohen and Sara K. Thompson , shareholders ... American Conference Institute’s 21st Drug & Medical Device Litigation Conference , taking place in ... , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... across the Dothan-Wiregrass Area in Alabama are expected to attend the UNCF Dothan-Wiregrass ... will help provide scholarship funds for area students and operating support to UNCF-member ...
(Date:12/2/2016)... ... December 02, 2016 , ... The annual time frame ... (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare beneficiaries who are looking ... prescription drug plan (Part D) need to make changes during this period order for ...
Breaking Medicine News(10 mins):